Home > Newsletters > International Pharmaceutical Regulatory Monitor > Brazil Looks to Expedite Clinical Trial Approvals With Fast-Track Regulation
International Pharmaceutical Regulatory Monitor
July 2012 | Vol. 40 No. 7
Brazil Looks to Expedite Clinical Trial Approvals With Fast-Track Regulation
Regulations on how clinical trial protocols are approved in Brazil may soon be amended to allow for swifter approvals if the protocols have already been approved by a country whose regulatory framework is recognized by Brazil, such as the U.S. Food and Drug Administration or European Medicines Agency.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.